Long-term survivors of non-small cell lung cancer after radiation therapy: The significance of histological type

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2769-2773

  Nakayama, Yuko ^a,b   Hayakaw, Kazushige ^a   Mitsuhashi, Norio ^a   Saito, Yoshihiro ^a   Niibe, Hideo ^a,b  

^a GUNMA UNIVERSITY   (Japan)

^b Department of Radiology ^*  (Japan)

Author keywords

Histological type; Long term survivors; Non small cell lung cancer; Radiation therapy

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0030809352     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rosenthal SA and Curran WJ: The significance of histology in non-small cell lung cancer. Cancer Treat Reviews 17: 409-425, 1990.
2. Hayakawa K, Mitsuhashi N, Nakajima N, Saito Y, Mitomo O, Nakayama Y, Katano S and Niibe H: Radiation therapy for stage IIII epidermoid carcinoma of the lung. Lung Cancer 8: 213-224, 1993.
3. Hayakawa K, Mitsuhashi N, Saito Y, Nakajima N and Niibe H Adverse chronic effects of high-dose irradiation on proximal bronchus in patients treated for bronchogenic carcinoma. Br J Radiol 66: 477-479, 1993.
4. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R and Rotman M: Long-term observation of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Therapy Oncology Group. Cancer 59: 1874-1881, 1987.
5. Filderman AE, Shaw C, Matthay RA: Lung cancer Part I. Etiology, Pathology, Natural history, Manifestations, and Diagnosis techniques. Invest Radiol 21: 80-90, 1986.
6. Geddes DM: The natural history of lung cancer. A review based on rates of tumor growth. Br J Dis Chest 73: 1-17, 1979.
7. Usuda K, Saito Y, Aikawa K, Sakurada A, Chen Y, Endo C, Kanma K, Sato M, Sagawa M and Fujimura S: Clinicopathological characteristics of tumor doubling time in primary lung cancer (in Japanese). Haigan 34: 875-881, 1994.
8. Mountain CF, Lukeman JM, Hammar SP, Chanberlain DW, Coulson WF, Page DL, Victor TA and Weiland LH: Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 35: 147-156, 1987.
9. Petrovich Z, Stanley K, Cox JD and Paig C: Radiotherapy in the management of locally advanced lung cancer of all cell types: Final reports of randomized trial. Cancer 48: 1335-1340, 1981.
10. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar R and Cox JD: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III trial in regionally advanced, unresectable non-smal cell lung cancer. J Natl Cancer Inst 87: 198-205, 1995.
11. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF and Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323: 940-945, 1990.
12. Pisch J, Malamud S, Harvey J and Beattie EJ: Simultaneous chemoradiation in advanced non-small cell lung cancer. Semin Oncol 9: 120-126, 1993.
13. Marino P, Preatoni A and Cantoni A: Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysis. Cancer 76: 593-601, 1995.
14. Dillman RO, Seagren SL, Herndon J and Green MR: Randomized trial of induction chemotherapy plus radiation therapy vs alone in stage III non-small cell lung cancer(NSCLC): Five-year follow up of CALGB 84-33. Proc Am Soc Clin Oncol 12: 329, 1993.